Vanderbilt-Ingram Cancer Center Archive — Page 3 of 29

(iStock)
April 22, 2026

Liquid biopsy predicts response to breast cancer immunotherapy

This minimally invasive and cost-effective alternative to tissue biopsy offers “an accessible tool for tailoring treatment strategies in breast cancer,” researchers reported April 22 in the journal Science Translational Medicine.

Stylized illustration of seven women shown from the shoulders up, depicted with varied hairstyles, skin tones, and clothing against a white background.
April 14, 2026

Genomic testing finds a higher prevalence of high-risk breast cancer in Black women

These findings highlight the critical need for tumor genomic testing for all patients to identify those with high-risk tumors, which occur more frequently in Black women, and which require more aggressive treatment to prevent recurrence.

Clinician in surgical attire reviews lung imaging on monitors beside a cone-beam CT scanner during a biopsy procedure.
April 9, 2026

How robotic bronchoscopy helped a Georgia man avoid unnecessary lung surgery

Oncologist Mohamed Shanshal, MD, said robotic bronchoscopy significantly improves getting patients the appropriate treatment as soon as possible, reducing their anxiety and improving care.

Promotional flyer for “The Future of Lung Cancer Care,” a lung cancer conference on Friday, May 8, 2026, hosted by Vanderbilt-Ingram Cancer Center and Vanderbilt Lung Institute in Nashville. The flyer includes venue and accreditation details alongside an illustration of lungs with highlighted tumor-like areas.
March 10, 2026

Lung cancer conference set for May 8

Vanderbilt-Ingram Cancer Center and the Vanderbilt Lung Institute will host “The Future of Lung Cancer Care,” a one-day educational event scheduled for May 8 from 8:30 a.m. to 2:30 p.m. at the Nashville Marriott at Vanderbilt University.

Olalekan Oluwole, MBBS, MPH, in a suit, stands beside Douglas Johnson, MD, MSCI, in a white medical coat, in a hospital corridor.
February 18, 2026

Patient with melanoma receives tumor-infiltrating lymphocyte therapy

The highly personalized treatment is currently approved for patients with advanced stages of melanoma whose tumors have grown despite immunotherapies and/or targeted therapies.

Before being sedated, Aaron Davis gives a thumbs up with his surgical team. (photo by Donn Jones)
February 12, 2026

Vanderbilt Health celebrates milestone for novel histotripsy procedure 

Appealing to patients for its noninvasive nature, it avoids many of the traditional drawbacks of surgeries that use incisions, including pain management.